Find and Pitch Jounalists, Get Your Story Covered

Tags: ad analytics alex schultz apple att brand marketing direct response

	Profile	Recent Articles on Subject
1	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	Salesforce or Veeva: How drugmakers can navigate the upcoming CRM split - about 2 months ago With uncertainty roiling Big Pharma, execs are placing lower-risk bets - about 2 months ago Will 2025 mark pharma’s pivot to bigger deals after years of lackluster M&A? - 3 months ago How pharma was instrumental in President Jimmy Carter’s global health efforts - 3 months ago How Alexion markets a rare disease drug by ‘starting with the end in mind’ - 4 months ago Big Pharma earnings hang hope on the next generation of blockbusters - 5 months ago Why pharma megamergers may become a relic of the past - 5 months ago Top pharma and biotech conferences 2025 - 6 months ago Big Pharma is often media shy. Merck’s chief comms officer is hoping to change that. - 7 months ago Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half - 8 months ago Has pharma emerged from the ‘age of uncertainty’? - 9 months ago The FDA pushes concrete plans to further diversity in clinical trials - 9 months ago Avoiding the pharma ‘junk pile’ with launch readiness, pipeline rigor and ‘quick kills’ - 10 months ago AstraZeneca’s $80B sales goal by 2030 reflects industry’s penchant for long-term bets - 11 months ago How pharma’s surging M&A is impacting the industry’s tech sector - 12 months ago As investors ‘lose trust’ in pharma’s business model, focused M&A strategies can help - about 1 year ago How to make 2024 a banner year for biopharma, despite the headwinds - about 1 year ago Pharma’s financial market will be a tale of two cities in 2024 - over 1 year ago Biopharma’s FTC headache deepens with guideline shifts years in the making - over 1 year ago Real Chemistry’s CEO on biopharma’s outlook in 2024 - over 1 year ago The thorniest questions facing pharma, according to a leading bioethicist - over 1 year ago How Big Pharma keeps the oncology engines hot with a host of strategies - over 1 year ago The PharmaVoice 100: Rare disease warriors - over 1 year ago
2	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	The kids are alright: How pharma can make inroads with Gen Z - about 2 months ago Big Pharma’s new DTC play: partnering with digital health providers - 4 months ago Oncology, obesity and more: Where pharma R&D is headed in 2025 - 4 months ago From Mr. Mucus to the Super Bowl, pharma tries offbeat marketing strategies - 5 months ago Pfizer’s quest for market share in the ‘high stakes battleground’ of oral GLP-1s - 5 months ago 2024 PharmaVoice 100s: Clinical Trial Pros - 5 months ago 3 FDA approval dates to watch in the year’s final push - 7 months ago BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings - 8 months ago M&A is ready to explode, and that’s good news for pharma layoffs - 8 months ago As the GLP-1 market booms, other healthcare companies are cashing in - 9 months ago Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work? - 11 months ago Pharma CFOs need R&D vigilance in tough economic times - about 1 year ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	As financial headwinds pick up, pharmas are aiming to squeeze more ROI from their R&D - about 2 months ago Pharma’s forecast for 2025: Sowing seeds of a rebound - 2 months ago Musk’s rare disease torpedo, hospitals’ pharma fix and other policies leaders are tracking - 3 months ago The ability to pivot will be ‘key’ as pharma’s tariff threat looms - 3 months ago PharmaVoice’s Crystal Ball: The industry’s AI future - 3 months ago 3 closely watched drugs that failed in the clinic - 4 months ago 2024 PharmaVoice 100s: Rare Disease Warriors - 5 months ago 2024 PharmaVoice 100s: Trailblazers - 6 months ago Why pharma should redefine ‘women’s health’ - 7 months ago What pharma has learned from AI - 8 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 10 months ago Where competition is heating up in pharma - 11 months ago The biggest questions hanging over pharma in 2024 - about 1 year ago Pharma execs sound off on trends and policies they’re tracking in 2024 - about 1 year ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - about 1 year ago 10 of our most read articles in 2023 - over 1 year ago 3 standout digital innovations in pharma this year - over 1 year ago PharmaVoice 100s: Entrepreneurs - over 1 year ago PharmaVoice 100s: Clinical trial gurus - over 1 year ago
4	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	On message! - 4 months ago
5	Kristina Monllos Digiday Senior marketing editor at Digiday. Rhode Islander. St. Louis marketingjournalism	Marketing Briefing: With RFK Jr. headed to HHS, what should pharma advertisers be thinking about? - 5 months ago
6	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 7 months ago
7	Nicholas Florko STAT News Reports on US health business. Washington, DC healthcarepolicy	STAT+: AbbVie dramatically outspent its pharma company rivals in 2023 to promote its drugs to doctors - 9 months ago STAT+: Medical marijuana companies are using pharma’s sales tactics with little of the same scrutiny - over 1 year ago
8	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Boehringer biosimilar frustrations, FTC warnings, and more - 12 months ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - about 1 year ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - over 1 year ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - over 1 year ago
9	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Pharmacy Focus: Limited Series - Celebrity Endorsements in Pharmaceuticals - about 1 year ago
10	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	Pharmacists Can Help to Optimize the Total Health of Patients with Heart Conditions - about 1 year ago

Journalists covering pharma marketing